Replies to post #86009 on Ocata Therapeutics Inc fka OCAT

[Edward]

Even in his PR statement he makes no reference if and when the trials will begin says only well positioned. “Following our recently completed institutional equity financing, we are well-positioned to initiate our phase 2 clinical trial for dry-AMD and our pivotal trial for SMD, both debilitating disease states with no effective therapeutic options and where we are dedicated to bringing these important therapies to patients in need.”